v3.26.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Assets    
Fixed maturity securities available-for-sale, at fair value (amortized cost of $6,229,802 and $6,081,997 as of March 31, 2026, and December 31, 2025, respectively) $ 6,133,789 $ 6,050,542
Cash and cash equivalents 549,040 582,493
Accrued investment income 56,344 56,073
Deferred acquisition costs 22,177 22,232
Premiums receivable 47,398 46,130
Other assets 122,692 116,007
Deferred tax asset 30,562 19,989
Total assets 6,962,002 6,893,466
Liabilities:    
Loss reserves 590,393 572,470
Unearned premiums 85,252 91,639
Other liabilities 197,956 129,695
Long-term borrowings 744,853 744,481
Total liabilities 1,618,454 1,538,285
Equity:    
Common stock ($0.01 par value; 600,000 shares authorized; 140,293 shares issued and outstanding as of March 31, 2026, and 142,209 shares issued and outstanding as of December 31, 2025) 1,403 1,422
Additional paid-in capital 1,609,712 1,706,481
Accumulated other comprehensive income (82,711) (30,143)
Retained earnings 3,815,144 3,677,421
Total equity 5,343,548 5,355,181
Total liabilities and equity $ 6,962,002 $ 6,893,466